Pure Global AI
NCT06319573Recruiting

The Impact of Personalized Prognostic Counseling on IVF Patient's Experience and Treatment Utilization

Evaluation of in Vitro Fertilisation Patients' Experience With a Personalized Prognostic Counseling Strategy and Its Impact on Treatment Utilization and Discontinuation
GinefivClinicalTrials.govother
Verified
Study focus
Disease/Condition
Infertility
Drug/Device/Intervention
Counseling Supported by Univfy® Report
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Ginefiv
Location
Barcelona,Madrid, Spain
Timeline & enrollment
Phase
N/A
Start date
Mar 19, 2024
End date
Feb 28, 2026
Enrollment
366 participants
Primary outcome

Treatment utilization (conversion) rate in the two groups,Patient experience responses,Validation of Univfy prediction upon CLBdR,Retention Rate,Time to Pregnancy

Summary

This study will be conducted in two phases. In the first phase, research subjects will be
 assigned to receive standard counseling. In the second phase, research subjects will receive
 Univfy counseling.

ICD-10 classifications
Female infertilityMale infertilityFemale infertility, unspecifiedFemale infertility of other originFemale infertility of uterine origin
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06319573
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06319573 through Pure Global AI's free database. This phase not specified trial is sponsored by Ginefiv and is currently Recruiting. The study focuses on Infertility. Target enrollment is 366 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.